DarioHealth Reports Q3 2026 Revenue Growth and Improved Operating Losses
DarioHealth (DRIO) reported third-quarter 2026 revenue of $5.3 million, marking a 6% year-over-year increase. The company demonstrated improved fiscal discipline, reducing operating expenses by 10% to $11.2 million and narrowing its net loss to $8.8 million compared to $10.5 million in the prior-year period. The company is seeing a significant shift in its revenue mix, with consumer revenue growing 48% year-over-year to account for 53% of total revenue. While gross margins saw a slight dip to 59% due to changes in revenue composition, the Non-GAAP B2B2C gross margin remained stable at approximately 80%. Strategic expansion continues through channel partnerships, including a new New Jersey health plan win via Amwell covering 1.5 million lives. However, management noted challenges regarding member retention and longer-than-expected timelines for converting administrative services agreements (ASO) into recognized revenue.
Topics: ARR Consumer Revenue Gross Margin Net Loss Operating Loss Revenue Growth